Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.1%

2 terminated out of 49 trials

Success Rate

92.6%

+6.1% vs benchmark

Late-Stage Pipeline

18%

9 trials in Phase 3/4

Results Transparency

8%

2 of 25 completed with results

Key Signals

2 with results93% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (3)
P 1 (8)
P 2 (3)
P 3 (4)
P 4 (5)

Trial Status

Completed25
Unknown11
Active Not Recruiting5
Not Yet Recruiting4
Terminated2
Withdrawn1

Trial Success Rate

92.6%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (49)

Showing 20 of 20 trials
NCT05212792RecruitingPrimary

Genomics and COVID-19 Vaccine Adverse Events

NCT05898464Phase 4Completed

Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV

NCT05283902Completed

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly

NCT07078357Phase 1Not Yet Recruiting

Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor

NCT05482295Phase 3Not Yet Recruiting

Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)

NCT05546502Phase 3Completed

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children

NCT06967428Phase 2Not Yet RecruitingPrimary

Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort

NCT06690515Phase 1Not Yet RecruitingPrimary

Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants

NCT04380701Phase 1Completed

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

NCT06180447Active Not RecruitingPrimary

Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy Outcomes

NCT04871841Completed

Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan

NCT04770649Terminated

Vaccine Observation to Include All Communities for Equitable Science

NCT05116748Completed

COVID19 Vaccine in SOT Adult Recipients

NCT05409261Phase 2Active Not Recruiting

Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine

NCT05409300Phase 2Active Not Recruiting

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

NCT05483725Active Not Recruiting

Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

NCT06286488Phase 4Active Not Recruiting

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

NCT04928911CompletedPrimary

Expectations About the COVID-19 Vaccines

NCT04691908Phase 3Completed

Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine

NCT04930003Phase 1Completed

Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine

Scroll to load more

Research Network

Activity Timeline